“Vaccine hesitancy” means scientists need to be more honest about risksBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d2479 (Published 15 April 2011) Cite this as: BMJ 2011;342:d2479
- Matthew Limb
Global vaccination programmes are on the brink of a successful new era, but they could yet be undermined by challenges, including a potential crisis of public trust, say experts.
A seminar heard how “vaccine hesitancy,” poor healthcare systems, and “unfair” pricing must be tackled to stop preventable diseases claiming millions more lives.
The debate, on vaccines and the opportunities they offer for global health, was held at the London School of Hygiene and Tropical Medicine on 13 April.
Speakers included specialists in the fields of vaccines development, immunisation strategy, and international aid and development.
Heidi Larson, of the London School of Hygiene and Tropical Medicine, who leads the school’s research programme on public trust in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial